Photoswitches for controllable RNA binding: a future approach in the RNA-targeting therapy

Daria V Berdnikova1

  • 1Universität Siegen, Organische Chemie II, Adolf-Reichwein-Str. 2, 57076 Siegen, Germany. berdnikova@chemie-bio.uni-siegen.de.

Chemical Communications (Cambridge, England)
|September 29, 2021
PubMed

Insights

Researchers are developing photoswitchable RNA binders for precise control over drug-target interactions. This innovative approach offers new therapeutic possibilities for infections, cancer, and genetic diseases by harnessing light-activated molecular switches.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Photochemistry

Background:

  • Ribonucleic acid (RNA) is a significant emerging target for therapeutic interventions across various diseases, including infections, cancer, and genetic disorders.
  • Developing selective and efficient ligands for RNA targeting is crucial for advancing therapeutic strategies.
  • Photoswitchable molecules offer light-controlled modulation of molecular interactions, presenting a promising avenue for precise therapeutic control.

Purpose of the Study:

  • To review the development of photoswitchable noncovalent RNA binders.
  • To highlight the potential of light-controlled RNA targeting in drug discovery.
  • To outline the current challenges and future perspectives in this interdisciplinary field.

Main Methods:

  • Exploration of design strategies for photoswitchable noncovalent RNA binders.
  • Analysis of photochemical properties and RNA binding selectivity.
  • Review of existing literature and case studies in the field.

Main Results:

  • Photoswitchable RNA binders offer high spatiotemporal control over ligand-RNA and protein-RNA interactions.
  • The design of lead structures requires balancing high RNA binding selectivity with efficient photochemical performance.
  • This field remains underexplored, indicating significant potential for future research and development.

Conclusions:

  • Photoswitchable noncovalent RNA binders represent a promising, yet underexplored, frontier in therapeutic development.
  • Further research into lead structure design is essential to overcome current limitations.
  • This approach holds potential for precise therapeutic control in treating various diseases.

Related Concept Videos

Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.7K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
69.6K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
269
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.3K